These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 19463875)

  • 1. Characterization of putative GRP- and NMB-receptor antagonist's interaction with human receptors.
    González N; Mantey SA; Pradhan TK; Sancho V; Moody TW; Coy DH; Jensen RT
    Peptides; 2009 Aug; 30(8):1473-86. PubMed ID: 19463875
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacology and selectivity of various natural and synthetic bombesin related peptide agonists for human and rat bombesin receptors differs.
    Uehara H; González N; Sancho V; Mantey SA; Nuche-Berenguer B; Pradhan T; Coy DH; Jensen RT
    Peptides; 2011 Aug; 32(8):1685-99. PubMed ID: 21729729
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Activation of neuromedin B-preferring bombesin receptors on rat glioblastoma C-6 cells increases cellular Ca2+ and phosphoinositides.
    Wang LH; Battey JF; Wada E; Lin JT; Mantey S; Coy DH; Jensen RT
    Biochem J; 1992 Sep; 286 ( Pt 2)(Pt 2):641-8. PubMed ID: 1326946
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of the peptide structural requirements for high affinity interaction with bombesin receptors.
    Lin JT; Coy DH; Mantey SA; Jensen RT
    Eur J Pharmacol; 1995 Dec; 294(1):55-69. PubMed ID: 8788416
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Peptide structural requirements for antagonism differ between the two mammalian bombesin receptor subtypes.
    Lin JT; Coy DH; Mantey SA; Jensen RT
    J Pharmacol Exp Ther; 1995 Oct; 275(1):285-95. PubMed ID: 7562561
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Receptor-activated currents in mouse fibroblasts expressing transfected bombesin receptor subtype cDNAs.
    Kusano K; Gainer H; Battey JF; Fathi Z; Wada E
    Am J Physiol; 1993 Oct; 265(4 Pt 1):C869-76. PubMed ID: 8238311
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development of bombesin analogs with conformationally restricted amino acid substitutions with enhanced selectivity for the orphan receptor human bombesin receptor subtype 3.
    Mantey SA; Coy DH; Entsuah LK; Jensen RT
    J Pharmacol Exp Ther; 2004 Sep; 310(3):1161-70. PubMed ID: 15102928
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Discovery of a novel class of neuromedin B receptor antagonists, substituted somatostatin analogues.
    Orbuch M; Taylor JE; Coy DH; Mrozinski JE; Mantey SA; Battey JF; Moreau JP; Jensen RT
    Mol Pharmacol; 1993 Oct; 44(4):841-50. PubMed ID: 7901752
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ability of various bombesin receptor agonists and antagonists to alter intracellular signaling of the human orphan receptor BRS-3.
    Ryan RR; Weber HC; Hou W; Sainz E; Mantey SA; Battey JF; Coy DH; Jensen RT
    J Biol Chem; 1998 May; 273(22):13613-24. PubMed ID: 9593699
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rational design of a peptide agonist that interacts selectively with the orphan receptor, bombesin receptor subtype 3.
    Mantey SA; Coy DH; Pradhan TK; Igarashi H; Rizo IM; Shen L; Hou W; Hocart SJ; Jensen RT
    J Biol Chem; 2001 Mar; 276(12):9219-29. PubMed ID: 11112777
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparative pharmacology of bombesin receptor subtype-3, nonpeptide agonist MK-5046, a universal peptide agonist, and peptide antagonist Bantag-1 for human bombesin receptors.
    Moreno P; Mantey SA; Nuche-Berenguer B; Reitman ML; González N; Coy DH; Jensen RT
    J Pharmacol Exp Ther; 2013 Oct; 347(1):100-16. PubMed ID: 23892571
    [TBL] [Abstract][Full Text] [Related]  

  • 12. GRP-preferring bombesin receptors increase generation of inositol phosphates and tension in rat myometrium.
    Amiot F; Leiber D; Marc S; Harbon S
    Am J Physiol; 1993 Dec; 265(6 Pt 1):C1579-87. PubMed ID: 8279518
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Potent bombesin antagonists with C-terminal Leu-psi(CH2-N)-Tac-NH2 or its derivatives.
    Cai RZ; Reile H; Armatis P; Schally AV
    Proc Natl Acad Sci U S A; 1994 Dec; 91(26):12664-8. PubMed ID: 7809097
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Internalization of the gastrin-releasing peptide receptor is mediated by both phospholipase C-dependent and -independent processes.
    Benya RV; Akeson M; Mrozinski J; Jensen RT; Battey JF
    Mol Pharmacol; 1994 Sep; 46(3):495-501. PubMed ID: 7935330
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ligand binding, internalization, degradation and regulation by guanine nucleotides of bombesin receptor subtypes: a comparative study.
    Wang LH; Mantey SA; Lin JT; Frucht H; Jensen RT
    Biochim Biophys Acta; 1993 Jan; 1175(2):232-42. PubMed ID: 8380344
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Discovery of high affinity bombesin receptor subtype 3 agonists.
    Wu JM; Nitecki DE; Biancalana S; Feldman RI
    Mol Pharmacol; 1996 Nov; 50(5):1355-63. PubMed ID: 8913368
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neuromedin B receptors retain functional expression when transfected into BALB 3T3 fibroblasts: analysis of binding, kinetics, stoichiometry, modulation by guanine nucleotide-binding proteins, and signal transduction and comparison with natively expressed receptors.
    Benya RV; Wada E; Battey JF; Fathi Z; Wang LH; Mantey SA; Coy DH; Jensen RT
    Mol Pharmacol; 1992 Dec; 42(6):1058-68. PubMed ID: 1336112
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacology of putative selective hBRS-3 receptor agonists for human bombesin receptors (BnR): affinities, potencies and selectivity in multiple native and BnR transfected cells.
    Sancho V; Moody TW; Mantey SA; Di Florio A; Uehara H; Coy DH; Jensen RT
    Peptides; 2010 Aug; 31(8):1569-78. PubMed ID: 20438784
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparative pharmacology of the nonpeptide neuromedin B receptor antagonist PD 168368.
    Ryan RR; Katsuno T; Mantey SA; Pradhan TK; Weber HC; Coy DH; Battey JF; Jensen RT
    J Pharmacol Exp Ther; 1999 Sep; 290(3):1202-11. PubMed ID: 10454496
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neuromedin B receptor activation causes tyrosine phosphorylation of p125FAK by a phospholipase C independent mechanism which requires p21rho and integrity of the actin cytoskeleton.
    Tsuda T; Kusui T; Jensen RT
    Biochemistry; 1997 Dec; 36(51):16328-37. PubMed ID: 9405068
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.